Average Co-Inventor Count = 5.69
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (11 from 1,777 patents)
2. Bristol-Myers Squibb Compnay (1 from 3,685 patents)
12 patents:
1. 12116408 - Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
2. 11858992 - Nucleic acids encoding antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
3. 11072654 - Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
4. 10906975 - Methods of treating autoimmune disease or chronic inflammation with antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
5. 10906965 - Methods of treating autoimmune disease or chronic inflammation wtih antibodies that bind peptidoglycan recognition protein 1
6. 10189904 - Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
7. 10179814 - Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
8. 10150809 - Antibodies that bind peptidoglycan recognition protein 1
9. 9663568 - Antibodies that bind peptidoglycan recognition protein 1
10. 9550830 - Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
11. 9000127 - Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
12. 8981061 - Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof